The committee heard updates from the CDC, FDA and CMS. The committee also heard reports from three CLIAC workgroups: the Clinical Laboratory Improvement Amendments (CLIA) Personnel Regulations Workgroup, the Nontraditional Testing Workflow Model Workgroup, and the Next Generation Sequencing (NGS) Workgroup.
Back to All Events
Earlier Event: April 8
Pediatric Advisory Committee
Later Event: April 15
Advisory Committee on Blood and Tissue Safety and Availability Authority